Author

Zezhou Zang

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Other primary malignancies are associated with inferior survival in multiple myeloma: a single-center matched retrospective cohort study

Other primary malignancies (OPMs) may complicate diagnostic assessment, treatment sequencing, and prognostic evaluation in multiple myeloma (MM). This study characterized the spectrum and timing of OPMs and evaluated their association with overall survival (OS). We retrospectively screened 461 unique patient...

Chang-Nian Li, Ya-Ru Wang, Lu-Lu Li et al. · Frontiers in Oncology · 0 citations

Open access Aug 2026

Biomarker implications of gene editing in hematologic diseases: latest updates from ASH 2025

Overall, ASH 2025 suggests a shift from achieving gene editing to quantifying efficacy, durability, and safety, with standardized biomarker frameworks likely to play an increasingly important role in future clinical translation.

Ze-Zhou Zang, Wei Zheng, Rui-Rong Xu et al. · Biomarker Research · 0 citations